Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT04350190 · COMPLETED
Trial details
- NCT number
- NCT04350190
- Sponsor
- Wei Jiang
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-14
- Primary completion
- 2022-09-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.